EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Safe and Effective Histotripsy Ablation of Human Liver Tumors in a Genetically Modified Porcine Model

Tamalika Paul iD, Jessica Gannon, Manali Powar iD, Cora Youngs, Cassandra S Poole iD, Carley M Elliott iD, Mackenzie K Woolls iD, Khan Imran Mohammad iD, Sherrie Clark-Deener iD, Christopher Byron iD, Michael Edwards iD, Sheryl Coutermarsh-Ott iD und 5 weitere

Cancers · 29.07.2026 · 18 (15) · 2432

DOI: 10.3390/cancers18152432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 29.07.2026. Verfasst von Tamalika Paul und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA 24061, USA. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Virginia-Maryland College of Veterinary Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver cancers are a major cause of morbidity and mortality in patients where effective, non-invasive treatment options remain limited.

Objective

Histotripsy is a non-invasive, non-thermal, image-guided focused ultrasound method of ablation that mechanically disrupts cells and offers a range of potential advantages over other ablation modalities. The lack of physiologically and anatomically relevant animal models of human liver cancer has significantly hindered biomedical device development, including histotripsy.

Methods

To address these limitations, we developed a clinically relevant large animal orthotopic, dual-tumor model of human liver cancer and utilized these unique animals to evaluate the safety and efficacy of histotripsy. Here, we utilized immunocompromised pigs with genetic modifications in their IL-2RG and RAG2 genes and orthotopically engrafted human hepatocellular carcinoma (HepG2/C3A) and pancreatic adenocarcinoma (Panc-1) cells within the liver. The models were designed to recapitulate primary and metastatic liver tumor phenotypes.

Results

Histotripsy enabled real-time visualization of the treatment by the formation of bubble clouds and accurate targeting of the lesions. Histological analysis confirmed the engraftment of tumor cells and the ablation of targeted tissue. Serum biomarkers demonstrated no significant differences in bilirubin, ALT, ALKP, or CK post-treatment, suggesting that histotripsy treatment was well tolerated with minimal hepatic dysfunction or hepatocellular injury.

Conclusions

These findings establish a novel, clinically relevant porcine model of primary and metastatic liver tumors and demonstrate the safety and feasibility of using this model for evaluating histotripsy as a noninvasive modality for precise tumor ablation.

Schlagwörter

Stichwörter der Autor:innen

cancerfocused ultrasoundhepatocellular carcinomapancreatic adenocarcinomapig

Autor:innen und Institutionen

  • Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA 24061, USA.
  • Department of Biomedical Engineering and Mechanics, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.
  • Graduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Roanoke, VA 24016, USA.
  • College of Science, Virginia Tech, Blacksburg, VA 24061, USA.
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA 24061, USA.
  • Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA 24061, USA.

ORCID-Profile: Tamalika Paul, Manali Powar, Cassandra S Poole, Carley M Elliott, Mackenzie K Woolls, Khan Imran Mohammad, Sherrie Clark-Deener, Christopher Byron, Michael Edwards, Sheryl Coutermarsh-Ott, Kristin Eden, Kiho Lee

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Virginia-Maryland College of Veterinary Medicine
  • Virginia Tech Institute for Critical Technology and Applied Science Center for Engineered Health
  • National Institutes of Health
  • Focused Ultrasound Foundation

Zitieren

APA

Paul, T., Gannon, J., Powar, M., Youngs, C., Poole, C. S., Elliott, C. M., Woolls, M. K., Mohammad, K. I., Clark-Deener, S., Byron, C., Edwards, M., Coutermarsh-Ott, S., Eden, K., Lee, K., Ziemlewicz, T. J., Vlaisavljevich, E., & Allen, I. C. (2026). Safe and Effective Histotripsy Ablation of Human Liver Tumors in a Genetically Modified Porcine Model. Cancers, 18(15), 2432. https://doi.org/10.3390/cancers18152432

Vancouver

Paul T, Gannon J, Powar M, Youngs C, Poole CS, Elliott CM, et al. Safe and Effective Histotripsy Ablation of Human Liver Tumors in a Genetically Modified Porcine Model. Cancers. 2026;18(15):2432. doi:10.3390/cancers18152432

BibTeX
@article{Paul2026,
  author = {Paul, Tamalika and Gannon, Jessica and Powar, Manali and Youngs, Cora and Poole, Cassandra S and Elliott, Carley M and Woolls, Mackenzie K and Mohammad, Khan Imran and Clark-Deener, Sherrie and Byron, Christopher and Edwards, Michael and Coutermarsh-Ott, Sheryl and Eden, Kristin and Lee, Kiho and Ziemlewicz, Timothy J and Vlaisavljevich, Eli and Allen, Irving C},
  title = {Safe and Effective Histotripsy Ablation of Human Liver Tumors in a Genetically Modified Porcine Model},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {2432},
  doi = {10.3390/cancers18152432}
}
Kostenlos starten →